SEC Form 4 · accession 0001179110-18-010836
MOMENTA PHARMACEUTICALS INC · MNTA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Craig A Wheeler
Officer — President & CEO · Director
Period of report
Aug 21, 2018
Accepted (ET)
Aug 23, 2018 · 4:20 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001235010
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2,F3 | Aug 21, 2018 | S | 1,969 | $27.43 | D | 183,360 | D | |
| Common StockF4 | holding | — | — | — | 361,996 | I | Craig Wheeler Revocable Trust | |
| Common Stock | holding | — | — | — | 36,725 | I | Craig A Wheeler 2016 Annuity Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person September 10, 2015.
- F2This transaction was executed in multiple trades at prices ranging from $27.25 to $27.50. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- F3Reflects a decrease of 5,345 shares of MNTA common stock transferred to the Craig Wheeler Revocable Trust on August 21, 2018.
- F4Reflects the transfer of 5,345 shares of MNTA common stock on August 21, 2018 to the Craig Wheeler Revocable Trust that were previously held directly by Mr. Wheeler.